The market miseries generated by Greece’s debt crisis yesterday made no dent in gains by drug maker Shenzhen Hepalink Pharmaceutical (深圳海普瑞藥業公司), following an initial public offering (IPO) that catapulted the company’s low-profile founders to the richest couple in China.
Shares of Shenzhen Hepalink, a maker of heparin, a blood thinner based on chemicals derived from pig intestines, rose 1.5 percent to 177.78 yuan yesterday, its second day of trading after the IPO raised 5.9 billion yuan (US$864 million).
The company’s share price jumped 18 percent in its debut on Thursday after starting at an IPO price of 148 yuan — a record for a share traded on a Chinese stock exchange.
PHOTO: REUTERS
Li Li (李鋰) and his wife, Li Tan (李坦), who own a combined 72 percent of the company’s shares following its IPO, now hold wealth estimated at more than 50 billion yuan.
That tops auto and battery maker BYD Co (比亞迪) chairman Wang Chuanfu’s (王傳福) fortune, which Shanghai-based research group Hurun had listed as the biggest in China at US$5.1 billion.
The better-than-expected IPO performance boosted confidence in the resilience of China’s share markets despite losses stemming partly from the Greek debt crisis.
Shanghai’s benchmark Composite Index fell 1.9 percent, or 51.32 points, to 2,688.38 yesterday, while the smaller Shenzhen Composite Index, where Shenzhen Hepalink is traded, dropped 2.2 percent to 1,064.17.
The Shanghai index lost 6.3 percent for the week following a huge sell-off in Wall Street because of fears the Greek debt crisis could spread in Europe.
Mindful of problems in 2008 when contaminated heparin imported from other Chinese companies was linked to hundreds of life-threatening allergic reactions and at least three deaths, Shenzhen Hepalink has made safety a top selling point. The company’s products are approved by the US Food and Drug Administration and regulators in other key major markets.
Shenzhen Hepalink’s strong debut was a windfall for Goldman Sachs, which invested US$4.9 million in a 12.5 percent stake in the company in 2007.
Semiconductor business between Taiwan and the US is a “win-win” model for both sides given the high level of complementarity, the government said yesterday responding to tariff threats from US President Donald Trump. Home to the world’s largest contract chipmaker, Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), Taiwan is a key link in the global technology supply chain for companies such as Apple Inc and Nvidia Corp. Trump said on Monday he plans to impose tariffs on imported chips, pharmaceuticals and steel in an effort to get the producers to make them in the US. “Taiwan and the US semiconductor and other technology industries
The US Federal Reserve is expected to announce a pause in rate cuts on Wednesday, as policymakers look to continue tackling inflation under close and vocal scrutiny from US President Donald Trump. The Fed cut its key lending rate by a full percentage point in the final four months of last year and indicated it would move more cautiously going forward amid an uptick in inflation away from its long-term target of 2 percent. “I think they will do nothing, and I think they should do nothing,” Federal Reserve Bank of St Louis former president Jim Bullard said. “I think the
SMALL AND EFFICIENT: The Chinese AI app’s initial success has spurred worries in the US that its tech giants’ massive AI spending needs re-evaluation, a market strategist said Chinese artificial intelligence (AI) start-up DeepSeek’s (深度求索) eponymous AI assistant rocketed to the top of Apple Inc’s iPhone download charts, stirring doubts in Silicon Valley about the strength of the US’ technological dominance. The app’s underlying AI model is widely seen as competitive with OpenAI and Meta Platforms Inc’s latest. Its claim that it cost much less to train and develop triggered share moves across Asia’s supply chain. Chinese tech firms linked to DeepSeek, such as Iflytek Co (科大訊飛), surged yesterday, while chipmaking tool makers like Advantest Corp slumped on the potential threat to demand for Nvidia Corp’s AI accelerators. US stock
Cryptocurrencies gave a lukewarm reception to US President Donald Trump’s first policy moves on digital assets, notching small gains after he commissioned a report on regulation and a crypto reserve. Bitcoin has been broadly steady since Trump took office on Monday and was trading at about US$105,000 yesterday as some of the euphoria around a hoped-for revolution in cryptocurrency regulation ebbed. Smaller cryptocurrency ether has likewise had a fairly steady week, although was up 5 percent in the Asia day to US$3,420. Bitcoin had been one of the most spectacular “Trump trades” in financial markets, gaining 50 percent to break above US$100,000 and
RSS